LUZHU BIOTECH-B 02480Hong Kong Stock Exchange

15.0000.07%( -0.010 )
Closed: Oct 12 · Delayed · Hong Kong Stock Exchange
LUZHU BIOTECH-B (02480) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2023-05-08
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100005YD8

Industry

Innovative Drugs & Biologics 1.38%
124 stocks in this industry
Down 78 Up 36
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-176.30M73/125
ROE (Last FY)-22.78%82/117

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
孔健 Executive Director
张琰平 Executive Director
彭玲 Executive Director
马骉 Non-Executive Director
孔双泉 Non-Executive Director
侯爱军 Independent Non-Executive Director
梁伟业 Independent Non-Executive Director
梁冶矢 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-09-15.

About this page

This page shows LUZHU BIOTECH-B (02480) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.